Zomedica Corp.

AMEX: ZOM · Real-Time Price · USD
0.10
0.00 (2.56%)
At close: Mar 04, 2025, 9:50 AM

Zomedica Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net Income
-6.7M -23.93M -9.16M -22.41M -489K -5.25M -6.38M -2.81M -5M -5.27M -3.94M -3.29M -6.35M -4.71M -4.04M -4.17M -4.98M -5.31M -2.45M
Depreciation & Amortization
2.03M 1.98M 1.93M 1.87M 1.6M 1.47M 1.36M 1.23M 1.15M 837K 819K 828.22K 107.18K 100.55K 103.65K 119.67K 123.6K 122.85K 163.9K
Stock-Based Compensation
473K 859K 1.1M 1.1M 1.67M 1.73M 1.76M 1.44M 1.92M 2.49M 2.04M 2.59M 1.44M 1.78M 1.28M 1.18M 187.97K 135.84K 155.02K
Other Working Capital
2.34M -627.86K -655K 2.32M -2.13M 1.26M -479K -1.97M -1.76M -886K -244K -2.28M -488.16K 96.67K 207.51K 187.66K -1.1M -302.39K 334.18K
Other Non-Cash Items
-2.24M 20.82M 4.48M 11.53M -2.17M -4K -655K 1.86M -400K 671K 279K -3.31K 656.00 11K 24.18K 6.02K 6.02K 6.02K 4.01K
Deferred Income Tax
-67.68K -192.32K -184K -1.3M -487K -592K n/a -2.36M n/a -661K -279K -2.51M 4.81K -504.13K 218.99K 51.2K n/a n/a 128.93K
Change in Working Capital
1.71M -981.84K -725K 4.38M -3.15M -1.02M -345K -1.75M -447K -2.11M -1.39M -5.03M -202.69K 1.58M -231.07K 135.88K -1M -677.25K -174.37K
Operating Cash Flow
-4.8M -6.62M -7.59M -4.82M -3.03M -3.68M -4.26M -2.38M -2.77M -4.05M -2.47M -4.9M -5M -1.74M -2.64M -2.68M -5.66M -5.72M -2.17M
Capital Expenditures
-1.09M -1.24M -2.36M 8.88M -6.53M -1.93M -4.97M -300K -575K -68K -83K -183.65K -201.17K -123.25K -18.1K -16.18K -613 n/a n/a
Cash Acquisitions
n/a n/a n/a -11.03M -12.71M -17.24M n/a -24.3M -24.3M n/a n/a -71.01M 147.83 1.16 75.00 n/a n/a n/a n/a
Purchase of Investments
-7.55M -433.91K 7.99M -10.84M 12.71M 8.07M -9.82M -15.05M -114.5M -1M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
-13.37M 5.38M 7.99M 9.01M 16.06M 17.24M -8.07M -127.79M 24.3M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
23.86M -479K -2.36M 121.32K -12.66M 17.18M 8.07M 152.09M -23.81M -369K -123K -71.4M 150.00 -96K 75.00 15K -613 n/a 1.01M
Investing Cash Flow
6.54M 3.71M 5.63M -3.87M -3.12M 23.32M -14.79M -15.35M -138.89M -1.44M -206K -71.58M -201.02K -123.25K -18.03K -1.18K -613 n/a 1.01M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -14.27M n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-70K n/a n/a n/a n/a n/a n/a n/a 8K n/a n/a 23K 400K -12.8M 32.01M 12.64M 28.59M 33.33M -348.22K
Financial Cash Flow
-70K n/a n/a -153.65K 7.34M n/a n/a -186.9 8K n/a n/a 23K 400K 1.47M 217.27M 12.64M 28.59M 33.33M 2.15M
Net Cash Flow
1.81M -3M -2.01M -8.83M -6.17M 19.6M -19.05M -17.7M -141.67M -5.57M -2.62M -76.46M -4.8M -392.04K 214.61M 9.96M 22.93M 27.61M 986.17K
Free Cash Flow
-5.88M -7.86M -9.95M 4.05M -9.55M -5.61M -9.23M -2.68M -3.35M -4.11M -2.55M -5.09M -5.2M -1.86M -2.66M -2.7M -5.66M -5.72M -2.17M